Development of poly(lactic-co-glycolic acid) microparticles with pH-sensitive drug release behaviors

Journal of Pharmaceutical Investigation

Volumn 45, Issue 2, 2015, Pages 151-156

  Lee, Jung Ok ^a   Youn, Yu Seok ^b   Lee, Deok Keun ^c   Cha, Kyung Hoi ^c   Lee, Eun Seong ^a  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Gyeonggi Institute of Science and Technology Promotion   (South Korea)

Author keywords

3 diethylaminopropylated poly(l lysine); PLGA microparticle; Tiotropium

Indexed keywords

3 DIETHYLAMINOPROPYLATED POLY(L LYSINE); POLYGLACTIN; POLYLYSINE; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; ENCAPSULATION; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROPARTICLE; PARTICLE SIZE; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RESPIRATORY ACIDOSIS;

EID: 84925105241     PISSN: 20935552     EISSN: 20936214     Source Type: Journal    
DOI: 10.1007/s40005-014-0157-9     Document Type: Article

References (17)

1. Barnes PJ (2004) Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 56:515–548
2. Bivas-Benita M, Zwier R, Junginger HE, Borchard G (2005) Non-invasive pulmonary aerosol delivery in mice by the endotracheal route. Eur J Pharm Biopharm 61:214–218
3. Bruno CM, Valenti M (2012) Acid-base disorders in patients with chronic obstructive pulmonary disease: a pathophysiological review. J Biomed Biotechnol 2012:915150
4. Budweiser S, Jorres RA, Pfeifer M (2008) Treatment of respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis 3:605–618
5. Disse B, Speck GA, Rominger KL, Witek TJ Jr, Hammer R (1999) Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. Life Sci 64:457–464
6. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM (2006) Global burden of COPD: systematic review and meta-analysis. Eur Respir J 28:523–532
7. Koumis T, Samuel S (2005) Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease. Clin Ther 27:377–392
8. Lee ES, Park KH, Kang D, Park IS, Min HY, Lee DH, Kim S, Kim JH, Na K (2007) Protein complexed with chondroitin sulfate in poly(lactide-co-glycolide) microspheres. Biomaterials 28:2754–2762
9. Lee JO, Oh KT, Kim D, Lee ES (2014) pH-sensitive short worm-like micelles targeting tumors based on the extracellular pH. J Mater Chem B 2(37):6363–6370. doi:10.1039/c4tb00779d
10. Lopez AD, Murray CC (1998) The global burden of disease, 1990–2020. Nat Med 4:1241–1243
11. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM (2008) Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-co-glycolide) and its derivatives. J Control Release 125:193–209
12. Oh KT, Oh YT, Oh NM, Kim K, Lee DH, Lee ES (2009) A smart flower-like polymeric micelle for pH-triggered anticancer drug release. Int J Pharm 375:163–169
13. Park SY, Baik HJ, Oh YT, Oh KT, Youn YS, Lee ES (2011) A smart polysaccharide/drug conjugate for photodynamic therapy. Angew Chem Int Ed 50:1644–1647
14. Park S, Kwag DS, Lee UY, Lee DJ, Oh KT, Youn YS, Lee ES (2014) Highly porous poly(lactide-co-glycolide) microparticles for sustained tiotropium release. Polym Advan Technol 25:16–20
15. Pauwels RA, Rabe KF (2004) Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364:613–620
16. Wang J, Jiang Y, Wang Y, Li H, Fawcett JP, Gu J (2007) Highly sensitive assay for tiotropium, a quaternary ammonium, in human plasma by high-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 21:1755–1758
17. Yoo NY, Youn YS, Oh NM, Oh KT, Lee DK, Cha KH, Oh YT, Lee ES (2011) Antioxidant encapsulated porous poly(lactide-co-glycolide) microparticles for developing long acting inhalation system. Colloids Surf B: Biointerfaces 88:419–424